Clinical Research Directory
Browse clinical research sites, groups, and studies.
PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults
Sponsor: Aspargo Labs, Inc
Summary
The study will evaluate the pharmacokinetics and relative bioavailability of two liquid metformin formulations (100 mg/mL and 250 mg/mL)
Official title: An Open-Label, Randomized, Crossover Study to Characterize the Pharmacokinetics and Relative Bioavailability of Liquid Metformin at 100 mg/mL and 250 mg/mL Compared With Standard Metformin Tablets
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-03-15
Completion Date
2026-05-28
Last Updated
2025-12-23
Healthy Volunteers
Yes
Conditions
Interventions
Liquid Metformin 100 mg/mL
A single oral dose of liquid metformin at a concentration of 100 mg/mL will be administered under fasting conditions in one treatment period of the crossover.
Liquid Metformin 250 mg/mL
A single oral dose of liquid metformin at a concentration of 250 mg/mL will be administered under fasting conditions in one treatment period of the crossover.